Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
SBFM: Sunshine Biopharma, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
SBFM
The Story
SBFM
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+4.1% / yr
Operating margin
-12.9%
ROIC
-20.6%
Financially safe
Stretched
Debt / equity
0.03×
Interest coverage
0.0×
Current ratio
4.22×
Sunshine Biopharma, Inc.
SBFM
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Sunshine Biopharma, Inc.
SBFM
NASDAQ
·
USD
·
Closed
$1.17
−4.88%
$1.17
−$0.06 (4.88%)
52W Range
0th
pctl
Volume
0.05×
avg
Mkt Cap
585691
USD
P/E
-0.0
TTM
Div Yield
–
ann
52W Range
0th
pctl
Volume
0.05×
avg
Market Cap
585691
USD
P/E Ratio
-0.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings